Cudkowicz ME - Search Results

1

Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes.

Lindborg SR, Goyal NA, Katz J, Burford M, Li J, Kaspi H, Abramov N, Boulanger B, Berry JD, Nicholson K, Mozaffar T, Miller R, Jenkins L, Baloh RH, Lewis R, Staff NP, Owegi MA, Dagher B, Blondheim-Shraga NR, Gothelf Y, Levy YS, Kern R, Aricha R, Windebank AJ, Bowser R, Brown RH Jr, Cudkowicz ME. Lindborg SR, et al. Among authors: cudkowicz me. Muscle Nerve. 2024 Jun;69(6):719-729. doi: 10.1002/mus.28093. Epub 2024 Apr 9. Muscle Nerve. 2024. PMID: 38593477 Clinical Trial.

2

An update on superoxide dismutase 1 in familial amyotrophic lateral sclerosis.

Cudkowicz ME, Brown RH Jr. Cudkowicz ME, et al. J Neurol Sci. 1996 Aug;139 Suppl:10-5. doi: 10.1016/0022-510x(96)00084-6. J Neurol Sci. 1996. PMID: 8899652 Review. No abstract available.

3

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis.

Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, Schoenfeld DA, Hosler BA, Horvitz HR, Brown RH. Cudkowicz ME, et al. Ann Neurol. 1997 Feb;41(2):210-21. doi: 10.1002/ana.410410212. Ann Neurol. 1997. PMID: 9029070

4

Intrathecal administration of recombinant human superoxide dismutase 1 in amyotrophic lateral sclerosis: a preliminary safety and pharmacokinetic study.

Cudkowicz ME, Warren L, Francis JW, Lloyd KJ, Friedlander RM, Borges LF, Kassem N, Munsat TL, Brown RH Jr. Cudkowicz ME, et al. Neurology. 1997 Jul;49(1):213-22. doi: 10.1212/wnl.49.1.213. Neurology. 1997. PMID: 9222193 Clinical Trial.

5

Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene.

Cudkowicz ME, McKenna-Yasek D, Chen C, Hedley-Whyte ET, Brown RH Jr. Cudkowicz ME, et al. Ann Neurol. 1998 Jun;43(6):703-10. doi: 10.1002/ana.410430604. Ann Neurol. 1998. PMID: 9629839

6

The pharmacokinetics and pharmaco-dynamics of Procysteine in amyotrophic lateral sclerosis.

Cudkowicz ME, Sexton PM, Ellis T, Hayden DL, Gwilt PR, Whalen J, Brown RH Jr. Cudkowicz ME, et al. Neurology. 1999 Apr 22;52(7):1492-4. doi: 10.1212/wnl.52.7.1492. Neurology. 1999. PMID: 10227642 Clinical Trial.

7

Increased oxidative damage to DNA in ALS patients.

Bogdanov M, Brown RH, Matson W, Smart R, Hayden D, O'Donnell H, Flint Beal M, Cudkowicz M. Bogdanov M, et al. Free Radic Biol Med. 2000 Oct 1;29(7):652-8. doi: 10.1016/s0891-5849(00)00349-x. Free Radic Biol Med. 2000. PMID: 11033417

8

Comparison of incremental with multipoint MUNE methods in transgenic ALS mice.

Shefner JM, Cudkowicz ME, Brown RH Jr. Shefner JM, et al. Among authors: cudkowicz me. Muscle Nerve. 2002 Jan;25(1):39-42. doi: 10.1002/mus.10000. Muscle Nerve. 2002. PMID: 11754183

9

Disease course unaltered by a single intracisternal injection of BMP-7 in ALS mice.

Dreibelbis JE, Brown RH Jr, Pastuszak KA, Smith ER, Kaplan PL, Cudkowicz ME. Dreibelbis JE, et al. Among authors: cudkowicz me. Muscle Nerve. 2002 Jan;25(1):122-3. doi: 10.1002/mus.1222. Muscle Nerve. 2002. PMID: 11754197 No abstract available.

10

Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice.

Ryu H, Smith K, Camelo SI, Carreras I, Lee J, Iglesias AH, Dangond F, Cormier KA, Cudkowicz ME, Brown RH Jr, Ferrante RJ. Ryu H, et al. Among authors: cudkowicz me. J Neurochem. 2005 Jun;93(5):1087-98. doi: 10.1111/j.1471-4159.2005.03077.x. J Neurochem. 2005. PMID: 15934930 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page